Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

1.

Lamotrigine clinical pharmacokinetics.

Rambeck B, Wolf P.

Clin Pharmacokinet. 1993 Dec;25(6):433-43. Review.

PMID:
8119045
2.

Clinical pharmacokinetics of oxcarbazepine.

May TW, Korn-Merker E, Rambeck B.

Clin Pharmacokinet. 2003;42(12):1023-42. Review.

PMID:
12959634
4.

Lamotrigine. A review of its pharmacological properties and clinical efficacy in epilepsy.

Goa KL, Ross SR, Chrisp P.

Drugs. 1993 Jul;46(1):152-76. Review.

PMID:
7691504
5.

Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.

Nevitt SJ, Sudell M, Weston J, Tudur Smith C, Marson AG.

Cochrane Database Syst Rev. 2017 Jun 29;6:CD011412. doi: 10.1002/14651858.CD011412.pub2. Review.

PMID:
28661008
6.

The clinical efficacy of lamotrigine as an antiepileptic drug.

Pellock JM.

Neurology. 1994 Nov;44(11 Suppl 8):S29-35. Review.

PMID:
7970004
7.

Pharmacokinetic interactions of the new antiepileptic drugs.

Rambeck B, Specht U, Wolf P.

Clin Pharmacokinet. 1996 Oct;31(4):309-24. Review.

PMID:
8896946
8.

Clinical pharmacokinetics of newer antiepileptic drugs. Lamotrigine, vigabatrin, gabapentin and oxcarbazepine.

Elwes RD, Binnie CD.

Clin Pharmacokinet. 1996 Jun;30(6):403-15. Review.

PMID:
8792055
9.

Pharmacokinetics, drug interactions and exposure-response relationship of eslicarbazepine acetate in adult patients with partial-onset seizures: population pharmacokinetic and pharmacokinetic/pharmacodynamic analyses.

Falc√£o A, Fuseau E, Nunes T, Almeida L, Soares-da-Silva P.

CNS Drugs. 2012 Jan 1;26(1):79-91. doi: 10.2165/11596290-000000000-00000. Review.

PMID:
22171585
10.

Clinical pharmacokinetics of anticonvulsants.

Hvidberg EF, Dam M.

Clin Pharmacokinet. 1976;1(3):161-88. Review.

PMID:
797496
11.

Pharmacokinetics, toxicology and safety of lamotrigine in epilepsy.

Biton V.

Expert Opin Drug Metab Toxicol. 2006 Dec;2(6):1009-18. Review.

PMID:
17125413
12.

Lamotrigine: pharmacokinetics.

Garnett WR.

J Child Neurol. 1997 Nov;12 Suppl 1:S10-5. Review.

PMID:
9429124
13.

The ideal pharmacokinetic properties of an antiepileptic drug: how close does levetiracetam come?

Perucca E, Johannessen SI.

Epileptic Disord. 2003 May;5 Suppl 1:S17-26. Review.

PMID:
12915337
14.

Lopinavir/ritonavir: a review of its use in the management of HIV infection.

Cvetkovic RS, Goa KL.

Drugs. 2003;63(8):769-802. Review.

PMID:
12662125
15.

Lamotrigine: an antiepileptic agent for the treatment of partial seizures.

Gilman JT.

Ann Pharmacother. 1995 Feb;29(2):144-51. Review.

PMID:
7756713
16.

Drug treatment of epilepsy in elderly people: focus on valproic Acid.

Stephen LJ.

Drugs Aging. 2003;20(2):141-52. Review.

PMID:
12534314
17.
18.

Pharmacokinetic variability of newer antiepileptic drugs: when is monitoring needed?

Johannessen SI, Tomson T.

Clin Pharmacokinet. 2006;45(11):1061-75. Review.

PMID:
17048972
19.

Clinical pharmacology of lamotrigine.

Peck AW.

Epilepsia. 1991;32 Suppl 2:S9-12. Review.

PMID:
1773780
20.

The clinical pharmacokinetics of the new antiepileptic drugs.

Perucca E.

Epilepsia. 1999;40 Suppl 9:S7-13. Review.

Supplemental Content

Support Center